Latest News

Findings point toward one of first therapies for Lou Gehrig's disease

Researchers have determined that a copper compound known for decades may form the basis for a therapy for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. In humans, prior to this, no therapy for ALS has ever been discovered that could extend lifespan more than a few additional months.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Copyright Confusion Has 'Chilling' Effects in Online Creative Publishing

  • Human mind: Making sense through order

  • Amputee makes history controlling two modular prosthetic limbs

  • Scientists map out how childhood brain tumors relapse

  • Scheduling sleep: Three nighttime habits to improve rest

  • Ability to balance on one leg may reflect brain health, stroke risk

  • Being humble: Research shows E.B. White was right in Charlotte's Web

  • Outreach program gets cessation help to smokers of low socioeconomic status

  • Yoga has potential to reduce risk factors of cardiovascular disease

  • How does prostate cancer form? Parkinson's Link?

  •